Q&A on the European Innovation Act: R&D procurement and IP
The European Commission published a Q&A on the European Innovation Act, explaining R&D procurement rules and IP support measures. R&D procurement currently represents about 0.6% (€17 billion) of annual EU public procurement expenditure, while other leading economies invest 5 to 8 times more. The Act would create common R&D procurement rules, providing legal certainty, and is expected to save public buyers €1 billion per year and generate €25.92 billion in additional annual profits for companies. A Competence Centre within EUIPO will support IP-backed finance and commercialisation.
Impact and considerations
Common R&D procurement rules and an IP-backed finance framework could lower barriers for innovative companies participating in EU public procurement, informing business development and investment decisions for technology and R&D-intensive firms.
Key points
- EU R&D procurement represents about 0.6% (€17 billion) of annual public procurement expenditure, while other leading economies invest 5 to 8 times more.
- The Act would create common R&D procurement rules, providing legal certainty for public buyers, including joint cross-border procurement.
- Public buyers are expected to save €1 billion per year, while companies gain €25.92 billion in additional annual profits.
- A Competence Centre within EUIPO will support IP-backed finance and commercialisation.
- The IP valuation methodology will not be mandatory, but EU institutions will use it in managing Union financial programmes.
Sources and time
- Primary source
- European Commission
- Other sources
- 0
- First source publication
- 9 Sept 2026, 06:00
- Page published
- 12 Sept 2026, 00:19
- Last updated
- 9 Sept 2026, 06:00
- Original links
- European Commission Press Corner：Questions and answers on the European Innovation Act (opens in a new tab)Primary source · en · Published 9 Sept 2026, 06:00